--- title: "BullFrog AI Regains Nasdaq Compliance and Extends Runway" type: "News" locale: "en" url: "https://longbridge.com/en/news/283695109.md" description: "BullFrog AI Holdings, Inc. (BFRG) has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million as of April 21, 2026, after raising capital through sales facilities. This strengthens its balance sheet and extends its cash runway into late 2027. The company is under a one-year monitoring period, with potential delisting if equity shortfalls occur. Management cites a commercial agreement with a top-five global pharmaceutical company as validation of its AI-driven biomedical platform. BullFrog AI focuses on using AI for drug discovery and development, aiming to reduce clinical trial failures." datetime: "2026-04-22T13:31:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283695109.md) - [en](https://longbridge.com/en/news/283695109.md) - [zh-HK](https://longbridge.com/zh-HK/news/283695109.md) --- # BullFrog AI Regains Nasdaq Compliance and Extends Runway ### Claim 30% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks BullFrog AI Holdings, Inc. ( (BFRG) ) has provided an announcement. On April 21, 2026, BullFrog AI Holdings, Inc. received a notice from Nasdaq that it had regained compliance with the exchange’s minimum stockholders’ equity requirement of $2.5 million. The company achieved this by raising capital through its at-the-market sales facility and an equity-line-of-credit facility, strengthening its balance sheet and extending its cash runway into late 2027. Nasdaq has placed BullFrog AI under a one-year mandatory panel monitoring period starting April 21, 2026, during which any renewed equity shortfall could lead directly to delisting proceedings unless a new hearing is requested. Management framed the compliance milestone as the result of executing first-quarter objectives, pointing to a March commercial agreement with a top-five global pharmaceutical company as key validation of its AI-driven biomedical platform and as support for its efforts to preserve shareholder value. **More about BullFrog AI Holdings, Inc.** BullFrog AI Holdings, Inc. is a technology company that uses artificial intelligence and machine learning to analyze complex biomedical data for drug discovery and development. Through collaborations with leading research institutions and its proprietary bfLEAP platform, the company aims to streamline therapeutic development and reduce clinical trial failure rates in the biopharmaceutical sector. BullFrog AI focuses on turning complex biological and biomedical datasets into actionable insights that can support pharmaceutical partners. Its market positioning centers on applying causal AI tools to improve decision-making in therapeutics development, with recent commercial traction including agreements with major global pharmaceutical companies. **Average Trading Volume:** 11,575,100 **Technical Sentiment Signal:** Sell **Current Market Cap:** $18.3M ### Related Stocks - [BFRG.US](https://longbridge.com/en/quote/BFRG.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [NDAQ.US](https://longbridge.com/en/quote/NDAQ.US.md) - [BFRGW.US](https://longbridge.com/en/quote/BFRGW.US.md) ## Related News & Research - [Lantern Pharma raises capital, plans AI platform spinoff](https://longbridge.com/en/news/286480334.md) - [BMY Stock Rises as Bristol Myers Brings Anthropic's Claude AI to 30,000 Employees](https://longbridge.com/en/news/287076466.md) - [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md) - [Wellgistics Health Enters Binding LOI for Multi-Asset Deal at $4.0B Combined Valuation](https://longbridge.com/en/news/287205641.md) - [Radnor Capital Management LLC Has $1.65 Million Stock Holdings in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/286893528.md)